Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Physical performance, toxicity, and quality of life as assessed by the physician and the patient

Luoma, ML ; Hakamies-Blomqvist, L ; Sjostrom, J ; Mouridsen, H ; Pluzanska, A ; Malmström, Per LU ; Bengtsson, NO ; Hultborn, R ; Ostenstaad, B and Mjaaland, I , et al. (2002) In Acta Oncologica 41(1). p.44-49
Abstract
The aim of this study was to study the relationship between physician-assessed quality of life parameters, i.e., toxicity and physical performance, and patients' self-reports of their quality of life (QoL). QoL was assessed at baseline and before each treatment. using the EORTC QLQ-C30. The WHO performance score (PS) and toxicity were assessed in physician interviews. The correlations between the WHO PS and the QLQ-C30 functioning scale scores varied from weak to moderate, depending on the scale. Strongest associations were found in physical-, social-, and role functioning, and in the global QoL. The QLQ-C30 nausea vomiting and diarrhea scales correlated moderately to corresponding WHO scores. A multiple linear regression analysis was used... (More)
The aim of this study was to study the relationship between physician-assessed quality of life parameters, i.e., toxicity and physical performance, and patients' self-reports of their quality of life (QoL). QoL was assessed at baseline and before each treatment. using the EORTC QLQ-C30. The WHO performance score (PS) and toxicity were assessed in physician interviews. The correlations between the WHO PS and the QLQ-C30 functioning scale scores varied from weak to moderate, depending on the scale. Strongest associations were found in physical-, social-, and role functioning, and in the global QoL. The QLQ-C30 nausea vomiting and diarrhea scales correlated moderately to corresponding WHO scores. A multiple linear regression analysis was used to analyze the contribution of WHO PS and toxicity variables to the global QoL. The best model explained only 16% of the variance of the global QoL score. The present findings highlight the importance of independent QoL assessments focused on those aspects of QoL not captured in clinical interviews with the physician. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Acta Oncologica
volume
41
issue
1
pages
44 - 49
publisher
Taylor & Francis
external identifiers
  • wos:000174996000007
  • pmid:11990517
  • scopus:0036214010
ISSN
1651-226X
language
English
LU publication?
yes
id
63eec2c7-782e-4566-b11a-833f4cca265a (old id 340443)
alternative location
http://www.ingentaconnect.com/content/tandf/sonc/2002/00000041/00000001/art00007
date added to LUP
2016-04-01 15:34:03
date last changed
2022-02-12 08:38:12
@article{63eec2c7-782e-4566-b11a-833f4cca265a,
  abstract     = {{The aim of this study was to study the relationship between physician-assessed quality of life parameters, i.e., toxicity and physical performance, and patients' self-reports of their quality of life (QoL). QoL was assessed at baseline and before each treatment. using the EORTC QLQ-C30. The WHO performance score (PS) and toxicity were assessed in physician interviews. The correlations between the WHO PS and the QLQ-C30 functioning scale scores varied from weak to moderate, depending on the scale. Strongest associations were found in physical-, social-, and role functioning, and in the global QoL. The QLQ-C30 nausea vomiting and diarrhea scales correlated moderately to corresponding WHO scores. A multiple linear regression analysis was used to analyze the contribution of WHO PS and toxicity variables to the global QoL. The best model explained only 16% of the variance of the global QoL score. The present findings highlight the importance of independent QoL assessments focused on those aspects of QoL not captured in clinical interviews with the physician.}},
  author       = {{Luoma, ML and Hakamies-Blomqvist, L and Sjostrom, J and Mouridsen, H and Pluzanska, A and Malmström, Per and Bengtsson, NO and Hultborn, R and Ostenstaad, B and Mjaaland, I and Valvere, V and Wist, E and Baldursson, G and Ahlgren, J and Blomqvist, C}},
  issn         = {{1651-226X}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{44--49}},
  publisher    = {{Taylor & Francis}},
  series       = {{Acta Oncologica}},
  title        = {{Physical performance, toxicity, and quality of life as assessed by the physician and the patient}},
  url          = {{http://www.ingentaconnect.com/content/tandf/sonc/2002/00000041/00000001/art00007}},
  volume       = {{41}},
  year         = {{2002}},
}